Market Tracker

04/25 4:24pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.591
Delayed Data
As of 4:00pm ET
 +0.0072 / +1.23%
Today’s Change
0.28
Today|||52-Week Range
0.77
+91.63%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.58
Today’s open0.58
Day’s range0.58 - 0.60
Volume771,510
Average volume (3 months)3,329,623
Market cap$173.8M
Dividend yield--
Data as of 4:00pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...+0.05+0.49%
OCXOncoCyte Corp0.000.00%
ABUSArbutus Biopharma Co...+0.05+1.52%
FBIOFortress Biotech Inc+0.29+8.84%
Data as of 4:00pm ET, 04/25/2017

Financials

Next reporting dateJuly 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts